Better U Review – At-Home Ketamine, and What the Label Says

Better U prescribes oral ketamine by telehealth and posts it to you, with integration coaching wrapped around it, for depression and anxiety — $500 to $2,076 across four packages, in 29 states. It names real psychiatrists, its disclaimers are unusually careful, and it puts a blood pressure cuff in the box. It is also selling an off-label, compounded, Schedule III controlled substance to be taken at home alone — where the one drug in this family the FDA did approve for depression requires two hours of monitoring in a clinic at every session.

What It Is and Who It Is For

Better U describes itself as offering “online ketamine therapy, holistic psychiatry, and alternative treatments” for people whose “traditional medications or therapies” have not worked. The core product is a course of at-home oral ketamine sessions, supported by a preparation call, an app, integration coaching and a text-based care team. It also sells talk therapy, “longevity treatments”, a ketamine pain cream and “peak performance” programmes.

The intended buyer is explicit and, frankly, sympathetic: someone with depression, anxiety, OCD or PTSD who has already tried conventional antidepressants and therapy without getting where they wanted. That is a large group, conventional treatment genuinely fails a substantial share of them, and ketamine is one of the more interesting things to happen in psychiatry in decades. None of what follows is a suggestion that these people are foolish for looking.

What follows is about the gap between the evidence for ketamine — which is real — and the evidence for this particular route, dose and setting, which is thinner than the marketing implies.

What the FDA Labels Actually Say

Because this is a prescription product, we went to the approved labelling rather than the marketing. Two documents settle the regulatory picture.

That is the comparison worth holding in your head. When the FDA approved a drug in this family for depression, it required a certified healthcare setting, a restricted distribution programme, and two hours of observation after every dose — because of sedation, dissociation and respiratory depression. Better U mails you the medication and you take it at home.

Being fair about the differences: esketamine nasal spray and low-dose oral racemic ketamine are not the same drug at the same dose by the same route. Oral ketamine has poor and variable bioavailability, and the doses used in at-home programmes are generally far below anaesthetic doses. A lower dose plausibly carries lower risk. But that is an inference, not a finding, and the at-home model has not been tested to anything like the standard the approved product was.

One more piece of the legal picture: ketamine is a Schedule III controlled substance under 21 CFR 1308.13 — listed as “Ketamine, its salts, isomers, and salts of isomers”, DEA code 7285. That scheduling reflects a recognised potential for abuse and dependence, and it is why the guideline quoted below talks about diversion.

The Evidence, Split by Route

“Evidence-based” appears repeatedly on Better U’s site. The word is doing a lot of work, because the evidence for ketamine in depression is overwhelmingly evidence for the intravenous route, and that is not what is being sold.

A national guideline body looked at exactly this formulation and said it should be confined to specialists attached to tertiary centres. A direct-to-consumer programme operating in 29 states is not straightforwardly that. Better U does employ named psychiatrists, which is a genuine point in its favour and more than several competitors manage — but the setting is the part the guideline is worried about, and posting medication to a home is the opposite of a tertiary centre.

On maintenance treatment specifically — which is what a 27-session package is — a 2022 systematic review in The Lancet Psychiatry found the whole global literature amounted to three randomised controlled trials, eight open-label trials and 30 case series and reports. Its authors judged maintenance ketamine to be of “therapeutic potential” while noting the methodological limitations and calling for properly powered studies.

How It Works, Step by Step

1. Free online assessment — the site’s step one, to “identify the right approach for you”
2. If qualified, you either select a treatment package directly or book a free virtual consultation
3. Ketamine consultation to determine candidacy for the programme
4. Virtual clinical appointment with a licensed clinician covering health history, lifestyle and goals, who “will determine a personalized program”
5. Medication arrives by post, followed by a treatment preparation appointment with a “Certified Integration Guide” — 30 minutes on the 5 and 9-session packages, 15 minutes on the 15 and 27-session ones
6. You take the sessions at home, guided by the app and member portal
7. Integration coaching sessions follow — one on the smallest package, up to six on the largest
8. 24/7 text access to a concierge team, with medical questions relayed to your clinician

Note step five. The larger the package, the shorter the preparation appointment — 30 minutes if you buy 5 sessions, 15 minutes if you buy 27. We would have expected that relationship to run the other way.

Every Package, and a Pricing Oddity

What is included in every package: the ketamine consultation, virtual clinical appointment, treatment preparation call, the ketamine sessions themselves, member portal access, integration coaching, a personal client concierge with 24/7 secure text, a free “Brain Box” starter kit and delivery of all medications. The Brain Box contains a blood pressure cuff, a meditation mask, “heart diffraction glasses” and a journal and pen.

On financing: the site advertises “Split Pay” from $45–$82 a month and “Guaranteed Approval Financing with Denefits” on the larger packages. Guaranteed approval means the lender is not assessing affordability. Borrowing $2,076 for a treatment you have not yet tried, in a category where a substantial share of people do not respond, is the kind of decision to make slowly and in the smallest increment available.

We could not find a refund or cancellation policy in the pages we retrieved. That is a significant gap on a purchase of this size, and we would ask about it in writing before paying.

What Better U Does Well

We have been sceptical above, so it is important to say clearly that this is a meaningfully better-run operation than most of what we see in this category.

• It names its clinicians, with credentials. A Medical Director who is a psychiatrist, described as having completed a combined internal medicine and psychiatry residency at the University of Iowa and geriatric psychiatry at Mayo Clinic Rochester; a second psychiatrist; a physician assistant; a registered nurse; and a licensed professional counsellor as Director of Psychotherapy. Those names are checkable, and most telehealth firms we review hide behind “our licensed providers”
• The disclaimers are genuinely careful. The site states that “results vary and benefits are not guaranteed for any individual”, and labels its testimonials “Individual results vary. These experiences reflect the views of the individuals only and do not represent medical advice or a guarantee of outcomes.” That is more restraint than this industry usually shows
• The blood pressure cuff is the right instinct. Ketamine raises blood pressure; shipping a cuff with an unsupervised dosing programme is a real safety measure rather than a gimmick
• Integration coaching is included, not upsold. The psychotherapeutic wrapper is where much of the plausible benefit of psychedelic-assisted approaches is thought to sit, and building it in is the correct design
• The assessment and consultation are free, so you can find out whether you are considered a candidate at no cost
• The 29 states are published openly, rather than discovered at checkout
• A named concierge with 24/7 messaging, with medical questions routed to a clinician

The Language We Would Push Back On

Against that, some of the copy claims more than the evidence supports, and one word is doing unearned work.

Eligibility, Contraindications and Who Should Not Do This

Availability: the programme is US-only, and Better U lists 29 states: Alaska, Arizona, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Iowa, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Mexico, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington and Wisconsin. If your state is not on that list, it is not available to you, and we make no claim about anywhere else.

Categories that consistently appear in ketamine safety guidance as reasons for caution or exclusion — and which a prescriber should be screening for:

• Uncontrolled high blood pressure or significant cardiovascular disease — ketamine raises blood pressure and heart rate, which is why the cuff is in the box
• A history of psychosis, or a personal or family history of psychotic illness
• A history of substance use disorder — ketamine is Schedule III with recognised abuse potential, and unsupervised supply at home is the harder version of that problem
• Pregnancy or breastfeeding
• Anyone under 18. Spravato’s label states it is not approved in paediatric patients and warns of increased suicidal thoughts and behaviours in young adults on antidepressants
• Acute suicidality. If you are in crisis, this route is not appropriate — contact 988 or emergency services
• Liver disease, and a history of bladder or urinary problems, given the urinary toxicity documented with heavier ketamine use

Common effects to expect during sessions, drawn from the approved labelling for this drug class: sedation, dissociation and perceptual changes, raised blood pressure, nausea, dizziness and anxiety. The boxed warning on the approved product also lists respiratory depression, observed in postmarketing experience. Nobody should take a first dose without another adult present, whatever the programme says.

Why This Is on a Weight-Loss Site

Because depression and obesity travel together, extensively and in both directions — 16,545 indexed records pair the two. Depression makes weight management harder; carrying excess weight raises the risk of depression; and treatment for either affects the other. Readers of this site are disproportionately likely to be dealing with both.

That association is a reason to take depression seriously and get it treated. It is not a reason to reach for the least-evidenced route first. If conventional treatment has not worked for you, the ordered path a psychiatrist would generally take runs through adequate trials of established treatments, then augmentation, then the third-line options — of which intravenous ketamine is one, in a supervised setting, and Spravato is another, under its REMS. At-home oral ketamine is not a cheaper version of those; it is a different, less-tested thing.

Legitimacy and Credentials

How It Compares

Who Should Consider It, and Who Should Look Elsewhere

It may be worth a conversation if:

• You have tried adequate courses of conventional treatment without adequate response, and have discussed ketamine with your own prescriber
• You have no cardiovascular, psychosis or substance-use contraindications, and a clinician has confirmed that
• Supervised options are genuinely out of reach — no REMS-certified Spravato site within travelling distance, no affordable infusion clinic
• You will start with the 5-session package, not finance $2,076 up front
• You have someone else in the house during sessions, and will actually use the blood pressure cuff
• You keep your existing psychiatrist in the loop rather than replacing them with a subscription

Look elsewhere if:

• You are in crisis or having thoughts of self-harm. Call or text 988. This is not the route
• You have not yet tried conventional treatment. This sits third-line at best, and the oral route sits below that
• You have a history of psychosis, or of substance use disorder
• You have uncontrolled hypertension or significant heart disease
• You would be taking sessions entirely alone in the house
• You would need guaranteed-approval financing to afford it. That is a signal about affordability, not an opportunity
• You are considering the “peak performance” or pain cream products. Neither has the evidence to justify a controlled substance

Pros and Cons

Limitations of This Review

Checked on 11 August 2026 against betterucare.com, plus the FDA-approved labelling for Ketalar and Spravato via the openFDA label API, 21 CFR 1308.13, the CANMAT ketamine task force recommendations, a 2022 Lancet Psychiatry systematic review, a 2025 Cochrane review, PubMed and the BBB.

We did not use the service. Nobody here completed the assessment, spoke to a clinician, received medication or took a session. We cannot tell you how thorough the screening is, how carefully candidates are excluded, what dose is prescribed, which pharmacy compounds it, or what the sessions are like — and the quality of screening is the single most important safety variable in this whole model. It is entirely possible that Better U’s clinicians screen rigorously; we simply have no way to know from outside.

Several things we could not find and have therefore not stated: the refund and cancellation policy, the compounding pharmacy, the prescribed dose range, the credentials behind the word “Certified” for integration guides, and any Trustpilot record. Prices and state availability change; verify on the live site.

On the regulatory comparison: Spravato is esketamine, given nasally, at doses and in a context that differ from low-dose oral racemic ketamine. We have set the two side by side because it is the clearest available benchmark for what regulators required when they assessed this drug family for depression — not because the products are equivalent. The CANMAT recommendations are Canadian and date from 2021; guidance evolves. Evidence levels describe the state of the literature, not a verdict on any individual’s outcome.

Nothing here is medical advice, and none of it should be used to start, stop or change treatment. Depression is a serious, treatable illness and the right treatment is a decision for you and a clinician who knows your history. If you are in crisis, contact emergency services or call or text 988.

Frequently Asked Questions

Verdict

Let us be clear about what this rating is not. It is not a claim that ketamine does not work for depression: single-infusion intravenous ketamine carries Level 1 evidence in treatment-resistant depression, and for people whom conventional treatment has failed, that matters enormously. Nor is it a claim that Better U is a cowboy operation. It names its psychiatrists. It writes “results vary and benefits are not guaranteed for any individual” on its own homepage. It builds integration coaching into every package rather than selling it separately, and it ships a blood pressure cuff because ketamine raises blood pressure. That is a company trying to do this properly.

The problem is structural, and it is not solved by good intentions. The FDA-approved label for ketamine covers anaesthesia only, by injection. The one product in this family approved for depression — Spravato — carries a boxed warning for sedation, dissociation and respiratory depression, is available only through a REMS, and requires that patients be “monitored for at least 2 hours at each treatment session” before being judged fit to leave. Better U posts you the medicine.

And on the evidence the marketing leans on: the word “evidence-based” is attached to the route that has the least. CANMAT grades non-intravenous racemic ketamine at Level 3 or 4, and wrote that oral formulations “should be limited to specialists with ketamine-prescribing expertise and affiliations with tertiary or specialized centers”. That is a description of a hospital, not a mailing list of 29 states.

If you are going to do this anyway — and for someone failed by conventional treatment, with no supervised option within reach, that is a defensible choice made with a clinician — then do it in the smallest increment. Take the free assessment. Buy the $500 package, not the $2,076 one. Refuse guaranteed-approval financing. Have someone else in the house. Use the cuff. And keep your own doctor in the loop, because a subscription is not a psychiatrist.